Assay ID | Title | Year | Journal | Article |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID751284 | Inhibition of Escherichia coli FabI using 2-dodecenoyl-CoA as substrate at pH 8 | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751294 | Antiplasmodial activity against liver stage of Plasmodium berghei ANKA expressing GFP infected in human Huh7.5 cells assessed as reduction in PB18S gene expression after 48 hrs by qRT-PCR analysis | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751281 | Antibacterial activity against Escherichia coli ATCC 8739 | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751279 | Hepatotoxicity in zebrafish larva expressing fabp10a:DsRed2 assessed as reduction in liver size at 60.2 uM measured at 6 days postfertilization by fluorescence microscopic analysis | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751276 | Hepatotoxicity in zebrafish larva expressing fabp10a:DsRed2 assessed as change in liver size at 3.6 to 60.2 uM measured at 6 days postfertilization by fluorescence microscopic analysis relative to control | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751288 | Inhibition of Plasmodium falciparum FabG using acetoacetyl-CoA as substrate | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751285 | Inhibition of Staphylococcus aureus FabI using dodecenoyl ACP at pH 7.8 | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751295 | Cytotoxicity against human Huh7.5 cells after 24 hrs by Cell-titerGlo luminescence assay | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751287 | Inhibition of Plasmodium falciparum FabZ using crotonoyl-CoA as substrate preincubated for 10 mins prior to substrate addition | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751293 | Antiplasmodial activity against liver stage of Plasmodium berghei ANKA expressing GFP infected in human Huh7.5 cells assessed as decrease in size at 10 uM after 48 hrs by immunofluorescence analysis | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751289 | Inhibition of Plasmodium falciparum FabI using crotonoyl-CoA as substrate preincubated for 10 mins prior to substrate addition | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751280 | Toxicity in zebrafish larva measured at 4 days postfertilization | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751286 | Inhibition of Mycobacterium tuberculosis FabI using 2-dodecenoyl-CoA as substrate at pH 6.8 | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751296 | Cytotoxicity against human KB cells after 72 hrs by Alamar Blue assay | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
AID751291 | Antiplasmodial activity against blood stage of chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 after 48 hrs by [3H]-hypoxanthine incorporation assay | 2013 | Journal of natural products, Jun-28, Volume: 76, Issue:6
| Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |